FDA-rejected Merck med gets E.U. approval

Merck's cholesterol drug Tredaptive received approval in the European Union, Iceland, and Norway, clearing the way for marketing in 29 nations; formerly known as Cordaptive, it was rejected by the FDA earlier this year. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.